30.01
price down icon0.66%   -0.20
after-market Dopo l'orario di chiusura: 30.01
loading
Precedente Chiudi:
$30.21
Aprire:
$30.39
Volume 24 ore:
21,608
Relative Volume:
0.89
Capitalizzazione di mercato:
$355.72M
Reddito:
$9.71M
Utile/perdita netta:
$-29.96M
Rapporto P/E:
-11.16
EPS:
-2.69
Flusso di cassa netto:
$-14.79M
1 W Prestazione:
-3.69%
1M Prestazione:
+2.07%
6M Prestazione:
+17.64%
1 anno Prestazione:
+87.91%
Intervallo 1D:
Value
$29.50
$31.08
Intervallo di 1 settimana:
Value
$29.09
$32.50
Portata 52W:
Value
$14.33
$33.78

Xoma Royalty Corp Stock (XOMA) Company Profile

Name
Nome
Xoma Royalty Corp
Name
Telefono
510-204-7239
Name
Indirizzo
2200 POWELL STREET, EMERYVILLE, CA
Name
Dipendente
13
Name
Cinguettio
@xomacorp
Name
Prossima data di guadagno
2024-11-05
Name
Ultimi documenti SEC
Name
XOMA's Discussions on Twitter

Confronta XOMA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
XOMA 30.01 355.72M 9.71M -29.96M -14.79M -2.69
VRTX 467.01 119.87B 10.63B -479.80M -1.35B 13.33
REGN 762.00 83.27B 13.85B 4.65B 3.32B 35.06
ARGX 567.90 33.96B 1.86B -40.29M -1.28B -4.16
ALNY 232.27 30.18B 2.09B -332.26M 16.06M -4.14
BNTX 101.87 24.42B 3.30B -501.07M 1.03B 11.54

Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-09-07 Downgrade Wedbush Outperform → Neutral
2021-06-29 Iniziato Aegis Capital Buy
2021-01-19 Reiterato H.C. Wainwright Buy
2018-01-18 Reiterato H.C. Wainwright Buy
2017-10-17 Ripresa H.C. Wainwright Buy
2017-09-05 Aggiornamento Wedbush Neutral → Outperform
2017-06-12 Iniziato H.C. Wainwright Buy
2016-11-14 Downgrade Wedbush Outperform → Neutral
2016-03-11 Reiterato Wedbush Outperform
2015-07-23 Downgrade Jefferies Buy → Hold
2015-07-22 Downgrade Ladenburg Thalmann Buy → Neutral
2015-07-22 Downgrade Piper Jaffray Overweight → Neutral
2014-10-10 Ripresa ROTH Capital Buy
2014-04-29 Aggiornamento MLV & Co Hold → Buy
2014-03-11 Downgrade MLV & Co Buy → Hold
2014-03-05 Reiterato Ladenburg Thalmann Buy
2013-10-31 Reiterato MLV & Co Buy
2013-05-09 Reiterato Ladenburg Thalmann Buy
2012-05-14 Iniziato Cowen & Co Outperform
2011-03-31 Reiterato MLV Capital Buy
2011-03-23 Reiterato RBC Capital Mkts Outperform
2011-01-06 Reiterato Ladenburg Thalmann Buy
2011-01-04 Reiterato Wedbush Outperform
Mostra tutto

Xoma Royalty Corp Borsa (XOMA) Ultime notizie

pulisher
Nov 16, 2024

Short Interest in XOMA Co. (NASDAQ:XOMA) Drops By 23.5% - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

XOMA Co. (NASDAQ:XOMA) Sees Large Decrease in Short Interest - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Xoma royalty corp CFO Thomas Burns sells shares worth $292,663 By Investing.com - Investing.com Australia

Nov 14, 2024
pulisher
Nov 14, 2024

Xoma CEO Owen Hughes sells $655,335 in stock - Investing.com India

Nov 14, 2024
pulisher
Nov 13, 2024

Xoma royalty corp CFO Thomas Burns sells shares worth $292,663 - Investing.com

Nov 13, 2024
pulisher
Nov 11, 2024

What Makes XOMA Royalty (XOMA) a New Buy Stock - Yahoo Finance

Nov 11, 2024
pulisher
Nov 11, 2024

XOMA Royalty Reports Third Quarter 2024 Financial Results and Recent Activities - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

What is HC Wainwright's Forecast for XOMA FY2025 Earnings? - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

XOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates - Yahoo Finance

Nov 10, 2024
pulisher
Nov 09, 2024

XOMA Royalty Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 09, 2024
pulisher
Nov 08, 2024

XOMA Royalty’s Third Quarter 2024 Financial Insights - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

XOMA Royalty: Q3 Earnings Snapshot - CT Insider

Nov 07, 2024
pulisher
Nov 07, 2024

XOMA Royalty (XOMA) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities - ForexTV.com

Nov 07, 2024
pulisher
Nov 07, 2024

Xoma reports Q3 EPS ($1.59), consensus (44c) - TipRanks

Nov 07, 2024
pulisher
Nov 07, 2024

XOMA Royalty Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

XOMA Reports Mixed Q3: FDA Approval Win Despite $17.2M Loss, Expands Portfolio | XOMA Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 06, 2024

XOMA stock soars to 52-week high, reaching $32 By Investing.com - Investing.com UK

Nov 06, 2024
pulisher
Nov 06, 2024

XOMA stock soars to 52-week high, reaching $32 - Investing.com

Nov 06, 2024
pulisher
Nov 05, 2024

XOMA (NASDAQ:XOMA) Shares Cross Above Two Hundred Day Moving AverageHere's Why - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

XOMA (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s Why - Defense World

Nov 05, 2024
pulisher
Oct 30, 2024

XOMA Royalty Corporation's (NASDAQ:XOMA) high institutional ownership speaks for itself as stock continues to impress, up 11% over last week - Simply Wall St

Oct 30, 2024
pulisher
Oct 29, 2024

XOMA stock soars to 52-week high, reaching $30.7 By Investing.com - Investing.com South Africa

Oct 29, 2024
pulisher
Oct 29, 2024

XOMA stock soars to 52-week high, reaching $30.7 - Investing.com India

Oct 29, 2024
pulisher
Oct 27, 2024

XOMA’s (XOMA) Buy Rating Reaffirmed at HC Wainwright - Defense World

Oct 27, 2024
pulisher
Oct 26, 2024

XOMA Co. (NASDAQ:XOMAO) Short Interest Down 40.0% in October - Defense World

Oct 26, 2024
pulisher
Oct 23, 2024

Twist Bioscience enters into purchase agreement with XOMA Royalty - MSN

Oct 23, 2024
pulisher
Oct 23, 2024

XOMA (NASDAQ:XOMA) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

Oct 23, 2024
pulisher
Oct 22, 2024

XOMA Royalty Corporation Acquires 50% of Twist's Existing Royalty and Milestone Economics for $15 Million - Marketscreener.com

Oct 22, 2024
pulisher
Oct 22, 2024

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience - The Manila Times

Oct 22, 2024
pulisher
Oct 22, 2024

XOMA Royalty Significantly Expands its Royalty and - GlobeNewswire

Oct 22, 2024
pulisher
Oct 22, 2024

Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash - The Bakersfield Californian

Oct 22, 2024
pulisher
Oct 21, 2024

Investors in XOMA Royalty (NASDAQ:XOMA) have seen favorable returns of 72% over the past year - Yahoo Finance

Oct 21, 2024
pulisher
Oct 19, 2024

Ellsworth Advisors LLC Makes New $516,000 Investment in XOMA Co. (NASDAQ:XOMA) - MarketBeat

Oct 19, 2024
pulisher
Oct 17, 2024

XOMA stock soars to 52-week high, reaching $30.49 - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

XOMA stock soars to 52-week high, reaching $30.49 By Investing.com - Investing.com South Africa

Oct 17, 2024
pulisher
Oct 15, 2024

XOMA Royalty's Preferred Shares: High-Yield Dividends From Biotech Royalties (NASDAQ:XOMA) - Seeking Alpha

Oct 15, 2024
pulisher
Oct 09, 2024

XOMA (NASDAQ:XOMA) Share Price Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat

Oct 09, 2024
pulisher
Oct 01, 2024

XOMA Co. (NASDAQ:XOMA) is Stonepine Capital Management LLC’s 6th Largest Position - Defense World

Oct 01, 2024
pulisher
Sep 29, 2024

PIMCO Strategic Income Fund, XOMA Corporation, Another 2 Companies Have A High Estimated Dividend Yield - Via News Agency

Sep 29, 2024
pulisher
Sep 29, 2024

Rhumbline Advisers Raises Stock Holdings in XOMA Co. (NASDAQ:XOMA) - Defense World

Sep 29, 2024
pulisher
Sep 28, 2024

XOMA (NASDAQ:XOMA) Shares Pass Above 200-Day Moving Average of $25.91 - Defense World

Sep 28, 2024
pulisher
Sep 28, 2024

XOMA (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving Average of $25.91 - MarketBeat

Sep 28, 2024
pulisher
Sep 24, 2024

XOMA Co. (NASDAQ:XOMAO) Announces $0.52 Quarterly Dividend - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

XOMA shares hold as analyst reiterates Buy rating post-FDA nod - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

XOMA Royalty gains FDA-approved asset for NPC By Investing.com - Investing.com Canada

Sep 23, 2024
pulisher
Sep 23, 2024

XOMA Royalty gains FDA-approved asset for NPC - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

XOMAOXOMA Royalty Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock Latest Stock News & Market Updates - StockTitan

Sep 23, 2024
pulisher
Sep 23, 2024

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. - GlobeNewswire

Sep 23, 2024
pulisher
Sep 23, 2024

Xoma notes FDA approval of Zevra’s MIPLYFFA in patients with NPC - TipRanks

Sep 23, 2024

Xoma Royalty Corp Azioni (XOMA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Xoma Royalty Corp Azioni (XOMA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
BURNS THOMAS M.
SVP, Finance & CFO
Nov 13 '24
Sale
29.94
9,775
292,664
14,553
Hughes Owen
Chief Executive Officer
Nov 11 '24
Option Exercise
0.00
53,360
0
56,860
Hughes Owen
Chief Executive Officer
Nov 13 '24
Sale
29.95
21,881
655,336
34,979
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):